We are live on ! Find out more
SGRY icon

Surgery Partners

138 hedge funds and large institutions have $2.2B invested in Surgery Partners in 2022 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 58 increasing their positions, 32 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

123% more capital inflows, than outflows

Capital inflows: $121M | Capital outflows: $54.1M

81% more repeat investments, than reductions

Existing positions increased: 58 | Existing positions reduced: 32

62% more call options, than puts

Call options by funds: $9.6M | Put options by funds: $5.89M

1.67% more ownership

Funds ownership: 102.75% → 104.42% (+1.7%)

1% more funds holding

Funds holding: 137 → 138 (+1)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

5% less first-time investments, than exits

New positions opened: 21 | Existing positions closed: 22

Holders
138
Holders Change
+1
Holders Change %
+0.73%
% of All Funds
2.37%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
21
Increased
58
Reduced
32
Closed
22
Calls
$9.6​M
Puts
$5.89​M
Net Calls
+$3.68​M
Net Calls Change
+$3.17​M

SGRY Hedge Fund Activity: Q3 2022 in Review

138 of the 5,833 institutional investors tracked by Wall St. Rank reported a position in Surgery Partners (SGRY) for Q3 2022, worth a combined $2.2B — down 18% from $2.67B a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of SGRY and 21 opened new positions — a net loss of 1 holder — while 32 trimmed existing stakes and 58 added.

The largest buyer was Cannell & Co, adding an estimated $17M. The largest seller was Point72 Asset Management, cutting an estimated $12.5M.

  • 138 institutional investors held Surgery Partners (SGRY) as of Q3 2022, up from 137 in Q2 2022.
  • Funds reported $2.2B of Surgery Partners stock for Q3 2022, down 18% quarter-over-quarter.
  • 21 funds opened new Surgery Partners positions in Q3 2022 and 22 closed out, a net change of -1 holder.
  • The largest Surgery Partners buyer in Q3 2022 was Cannell & Co, an estimated $17M added.
  • The largest Surgery Partners seller in Q3 2022 was Point72 Asset Management, an estimated $12.5M sold.

Based on aggregated 13F filings for Q3 2022.